Incyte | Vermögenswerte



Assets Veränderung Datum
Acadia Pharmaceuticals USD 1.13B 55.39M 2025-03
Agios Pharmaceuticals USD 1.56B 107.68M 2025-03
Alnylam Pharmaceuticals USD 4.21B 26.17M 2025-03
Amgen USD 89.37B 2.47B 2025-03
Biogen USD 28.03B 16.2M 2025-03
BioMarin Pharmaceutical USD 7.15B 158.07M 2025-03
Bristol-Myers Squibb USD 92.43B 176M 2025-03
Eli Lilly USD 89.39B 10.67B 2025-03
Exelixis USD 2.84B 110.44M 2025-04
Gilead Sciences USD 56.43B 2.56B 2025-03
Incyte USD 5.75B 305.04M 2025-03
Ionis Pharmaceuticals USD 2.81B 190.73M 2025-03
MacroGenics USD 261.65M 2.84M 2024-12
Merck USD 115.12B 1.98B 2025-03
Moderna USD 12.7B 1.44B 2025-03
Neurocrine Biosciences USD 3.72B 183.7M 2024-12
Novartis USD 102.25B 1.28B 2024-12
Novartis USD 102.25B 1.28B 2024-12
Pfizer USD 208.03B 5.37B 2025-03
PTC Therapeutics USD 2.66B 950.36M 2025-03
Regeneron Pharmaceuticals USD 37.55B 214.2M 2025-03
Sarepta Therapeutics USD 3.47B 497.79M 2025-03
Ultragenyx Pharmaceutical USD 1.31B 191.53M 2025-03
Vertex Pharmaceuticals USD 22.53B 293M 2024-12



Incyte Vermögenswerte - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Jul 2025.